List prices in drug ads on TV coming as CMS finalizes rule
Despite numerous comments raising questions about a proposal to include list prices in pharmaceutical direct-to-consumer (DTC) advertisements, the Centers for Medicare and Medicaid Services (CMS) on Wednesday moved ahead and finalized the proposal.
The final rule, which will take effect in July, requires that television advertisements for prescription drugs or biological products with a list price of $35 or more contain a statement indicating the Wholesale Acquisition Cost (also referred to as WAC or the list price) for a typical 30-day regimen or for a typical course of treatment, whichever is most appropriate.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.